UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products

Therapeutic innovation & regulatory science, 2020-05, Vol.54 (3), p.693-700

2020

Volltextzugriff (PDF)

Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers

Drug metabolism and pharmacokinetics, 2019-08, Vol.34 (4), p.247-252

2019

Volltextzugriff (PDF)

Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females

The AAPS journal, 2017-07, Vol.19 (4), p.1196-1204

2017

Volltextzugriff (PDF)

Tolerability and Pharmacokinetics of Lobeglitazone (CKD-501), a Peroxisome Proliferator-Activated Receptor-γ Agonist: A Single- and Multiple-Dose, Double-Blind, Randomized Control Study in Healthy Male Korean Subjects

Clinical therapeutics, 2011-11, Vol.33 (11), p.1819-1830

2011

Volltextzugriff (PDF)

Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment

Translational and Clinical Pharmacology, 2019, 27(3), , pp.107-114

2019

Volltextzugriff (PDF)

Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin

Journal of clinical pharmacology, 2013-01, Vol.53 (1), p.75-81

2013

Volltextzugriff (PDF)

Comparative Pharmacokinetics and Tolerability of Branded Etanercept (25 mg) and Its Biosimilar (25 mg): A Randomized, Open-Label, Single-Dose, Two-Sequence, Crossover Study in Healthy Korean Male Volunteers

Clinical therapeutics, 2011-12, Vol.33 (12), p.2029-2037

2011

Volltextzugriff (PDF)

Pharmacometabolomic prediction for hepatic CYP3A-mediated drug interaction by administration of moderate inhibitor or inducer

Drug metabolism and pharmacokinetics, 2017-01, Vol.32 (1), p.S41-S41

2017

Volltextzugriff (PDF)

Validated LC–MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies

Journal of chromatographic science, 2015-09, Vol.53 (8), p.1250-1256

2015

Volltextzugriff (PDF)

Pharmacokinetic–Pharmacodynamic Relationships of Macitentan, a New Endothelin Receptor Antagonist, After Multiple Dosing in Healthy Korean Subjects

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2014-10, Vol.14 (5), p.377-385

2014

Volltextzugriff (PDF)

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity

Genomics & Informatics, 2018, 16(3), , pp.52-58

2018

Volltextzugriff (PDF)

Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D610 allele in healthy Korean subjects

British journal of clinical pharmacology, 2008-11, Vol.66 (5), p.660-666

2008

Volltextzugriff (PDF)

Pharmacokinetics of Extended-Release Versus Conventional Tramadol/Acetaminophen Fixed-Dose Combination Tablets: An Open-Label, 2-Treatment, Multiple-Dose, Randomized-Sequence Crossover Study in Healthy Korean Male Volunteers

Clinical therapeutics, 2011-06, Vol.33 (6), p.728-737

2011

Volltextzugriff (PDF)

Changes in the QTc interval after administration of flecainide acetate, with and without coadministered Paroxetine, in Relation to Cytochrome P450 2D6 Genotype: Data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects

Clinical therapeutics, 2010-04, Vol.32 (4), p.659-666

2010

Volltextzugriff (PDF)

Synthesis of diverse aryl‐substituted amino propanes

Bulletin of the Korean Chemical Society, 2024, 45(3), , pp.247-251

2024

Volltextzugriff (PDF)

The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: An open-label, one-sequence, three-period, three-treatment crossover study

Clinical therapeutics, 2009-12, Vol.31 (12), p.3009-3020

2009

Volltextzugriff (PDF)

Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-07, Vol.326 (3), p.240

2021

Volltextzugriff (PDF)

Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/Ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers

Clinical therapeutics, 2009-10, Vol.31 (10), p.2249-2257

2009

Volltextzugriff (PDF)

Regulatory news: Dojolvi (triheptanoin) as a source of calories and fatty acids in long‐chain fatty acid oxidation disorders: FDA approval summary

Journal of inherited metabolic disease, 2021-05, Vol.44 (3), p.515-517

2021

Volltextzugriff (PDF)

A bioequivalence study of two levofloxacin tablets in healthy male subjects

Translational and Clinical Pharmacology, 2014, 22(2), , pp.102-105

2014

Volltextzugriff (PDF)

In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products

Therapeutic innovation & regulatory science, 2019-10, p.2168479019875338-2168479019875338

2019

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations

European journal of drug metabolism and pharmacokinetics, 2017-12, Vol.42 (6), p.973-980

2017

Volltextzugriff (PDF)

Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation

Biopharmaceutics & drug disposition, 2019-04, Vol.40 (3-4), p.135-150

2019

Volltextzugriff (PDF)

A Population Pharmacokinetic Model of Intravenous Dexmedetomidine for Mechanically Ventilated Children after Neurosurgery

Journal of clinical medicine, 2019-10, Vol.8 (10), p.1563

2019

Volltextzugriff (PDF)

Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects

European journal of clinical pharmacology, 2018-10, Vol.74 (10), p.1261-1272

2018

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products

Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers

Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females

Tolerability and Pharmacokinetics of Lobeglitazone (CKD-501), a Peroxisome Proliferator-Activated Receptor-γ Agonist: A Single- and Multiple-Dose, Double-Blind, Randomized Control Study in Healthy Male Korean Subjects

Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment

Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin

Comparative Pharmacokinetics and Tolerability of Branded Etanercept (25 mg) and Its Biosimilar (25 mg): A Randomized, Open-Label, Single-Dose, Two-Sequence, Crossover Study in Healthy Korean Male Volunteers

Pharmacometabolomic prediction for hepatic CYP3A-mediated drug interaction by administration of moderate inhibitor or inducer

Validated LC–MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies

Pharmacokinetic–Pharmacodynamic Relationships of Macitentan, a New Endothelin Receptor Antagonist, After Multiple Dosing in Healthy Korean Subjects

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity

Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D610 allele in healthy Korean subjects

Pharmacokinetics of Extended-Release Versus Conventional Tramadol/Acetaminophen Fixed-Dose Combination Tablets: An Open-Label, 2-Treatment, Multiple-Dose, Randomized-Sequence Crossover Study in Healthy Korean Male Volunteers

Changes in the QTc interval after administration of flecainide acetate, with and without coadministered Paroxetine, in Relation to Cytochrome P450 2D6 Genotype: Data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects

Synthesis of diverse aryl‐substituted amino propanes

The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: An open-label, one-sequence, three-period, three-treatment crossover study

Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial

Regulatory news: Dojolvi (triheptanoin) as a source of calories and fatty acids in long‐chain fatty acid oxidation disorders: FDA approval summary

A bioequivalence study of two levofloxacin tablets in healthy male subjects

In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products

Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations

Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation

A Population Pharmacokinetic Model of Intravenous Dexmedetomidine for Mechanically Ventilated Children after Neurosurgery

Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects

Suchergebnisse filtern